Journal Article Review Epublish 137 citations
PubMed: 32231672 DOI: 10.3389/fimmu.2020.00454
The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Front Immunol 11:454
Authors: Elie Nader, Marc Romana, Philippe Connes
Affiliations
- Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team Vascular Biology and Red Blood Cell, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
- Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France.
- Université des Antilles, UMR_S1134, BIGR, Pointe-à-Pitre, France.
- Université de Paris, UMR_S1134, BIGR, INSERM, Paris, France.
Abstract
Sickle cell disease (SCD) is a genetic disease caused by a single mutation in the β-globin gene, leading to the production of an abnormal hemoglobin called hemoglobin S (HbS), which polymerizes under deoxygenation, and induces the sickling of red blood cells (RBCs). Sickled RBCs are very fragile and rigid, and patients consequently become anemic and develop frequent and recurrent vaso-occlusive crises. However, it is now evident that SCD is not only a RBC rheological disease. Accumulating evidence shows that SCD is also characterized by the presence of chronic inflammation and oxidative stress, participating in the development of chronic vasculopathy and several chronic complications. The accumulation of hemoglobin and heme in the plasma, as a consequence of enhanced intravascular hemolysis, decreases nitric oxide bioavailability and enhances the production of reactive oxygen species (ROS). Heme and hemoglobin also represent erythrocytic danger-associated molecular pattern molecules (eDAMPs), which may activate endothelial inflammation through TLR-4 signaling and promote the development of complications, such as acute chest syndrome. It is also suspected that heme may activate the innate immune complement system and stimulate neutrophils to release neutrophil extracellular traps. A large amount of microparticles (MPs) from various cellular origins (platelets, RBCs, white blood cells, endothelial cells) is also released into the plasma of SCD patients and participate in the inflammation and oxidative stress in SCD. In turn, this pro-inflammatory and oxidative stress environment further alters the RBC properties. Increased pro-inflammatory cytokine concentrations promote the activation of RBC NADPH oxidase and, thus, raise the production of intra-erythrocyte ROS. Such enhanced oxidative stress causes deleterious damage to the RBC membrane and further alters the deformability of the cells, modifying their aggregation properties. These RBC rheological alterations have been shown to be associated to specific SCD complications, such as leg ulcers, priapism, and glomerulopathy. Moreover, RBCs positive for the Duffy antigen receptor for chemokines may be very sensitive to various inflammatory molecules that promote RBC dehydration and increase RBC adhesiveness to the vascular wall. In summary, SCD is characterized by a vicious circle between abnormal RBC rheology and inflammation, which modulates the clinical severity of patients.
MeSH
Cells, Genes, Hemoglobins, Erythrocytes, Blood, Anemia, Sickle Cell, Stress, Physiological, Neutrophils, Oxidative Stress, Heme, Immune System Diseases, Globins, Hemolysis, Endothelial Cells, Blood Cells, Plasma
Cited by
- Targeting Neutrophil Adhesive Events to Address Vaso-Occlusive Crisis in Sickle Cell Patients. Front Immunol, 2021
- CD4 T Cell Profile and Activation Response in Sickle Cell Disease Patients with Osteonecrosis. Mediators Inflamm, 2020
- Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections. Antioxidants (Basel), 2020
- Heme-Mediated Selection of Encapsulated Streptococcus pneumoniae in the Lungs by Oxidative Stress. bioRxiv, 2023
- Stress erythropoiesis: definitions and models for its study. Exp Hematol, 2020
- The hematopoietic saga of clonality in sickle cell disease. J Clin Invest, 2022
- Extracellular Vesicles From Stored Red Blood Cells Convey Heme and Induce Spic Expression on Human Monocytes. Front Immunol, 2022
- IFN-I promotes T-cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD. Blood, 2025
- Neuroinflammation underlies the development of social stress induced cognitive deficit in sickle cell disease. bioRxiv, 2024
- Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction. Ann Blood, 2021
- Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications. Medicine (Baltimore), 2024
- Cilia proteins are biomarkers of altered flow in the vasculature. JCI Insight, 2022
- Biomechanical Assessment of Red Blood Cells in Pulsatile Blood Flows. Micromachines (Basel), 2023
- Neuroinflammation underlies the development of social stress induced cognitive deficit in male sickle cell mice. Exp Biol Med (Maywood), 2024
- Heme-mediated selection of encapsulated Streptococcus pneumoniae in the lungs by oxidative stress. Emerg Microbes Infect, 2025
- Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease. Br J Haematol, 2025
- Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events? Blood Adv, 2021
- Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. Int J Mol Sci, 2021
- The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus. Cell, 2023
- Improving the Emergency Department Management of Sickle Cell Vaso-Occlusive Pain Crisis: The Role and Options of Sublingual and Intranasally Administered Analgesia. J Clin Med Res, 2023